IMPACT, Food & Mood Centre, School of Medicine, Barwon Health, Deakin University, Geelong, VIC, Australia.
School of Psychology, Deakin University, Melbourne, VIC, Australia.
Lancet Gastroenterol Hepatol. 2021 May;6(5):401-410. doi: 10.1016/S2468-1253(20)30363-0. Epub 2021 Feb 13.
The frequent co-occurrence of irritable bowel syndrome and the common mental disorders of anxiety and depression is well established. A range of biological and psychosocial disease mechanisms are common to both disorders, many of which contribute to a dysregulated gut-brain axis. Clinical and subthreshold psychological comorbidity adds to the functional impairment and disease burden in individuals with irritable bowel syndrome. Progress is being made with regard to understanding irritable bowel syndrome in the clinical setting from a biopsychosocial perspective. However, until now, most trials of irritable bowel syndrome treatment still consider the disease as a gut disorder in isolation, which leaves major gaps in knowledge about disease-disease interactions and treatment outcomes in irritable bowel syndrome. In this Viewpoint, we review the epidemiology, pathophysiology, and management of anxiety and depression in individuals with irritable bowel syndrome. We also provide methodological recommendations for future randomised controlled trials and outline guidance for research that better incorporates psychiatric comorbidity into its design, with a view to improve treatment outcomes for individuals with irritable bowel syndrome.
肠易激综合征与焦虑和抑郁等常见精神障碍经常同时发生,这一点已得到充分证实。这两种疾病存在一系列共同的生物学和心理社会发病机制,其中许多机制导致了肠道-大脑轴的失调。在患有肠易激综合征的个体中,临床和亚临床心理共病增加了其功能障碍和疾病负担。从生物心理社会角度理解肠易激综合征的临床情况方面正在取得进展。然而,到目前为止,大多数肠易激综合征治疗试验仍然将该疾病视为孤立的肠道疾病,这导致了对肠易激综合征疾病-疾病相互作用和治疗结果的知识存在重大空白。在本观点文章中,我们回顾了肠易激综合征患者中焦虑和抑郁的流行病学、病理生理学和管理。我们还为未来的随机对照试验提供了方法学建议,并概述了将精神共病更好地纳入其设计的研究指南,以期改善肠易激综合征患者的治疗效果。